APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dried Blood Spot (DBS) Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dried Blood Spot (DBS) Testing Market Analysis and Forecast 2026-2032

2 May 2026185 pages

Choose your research edition.

Industry ResearchDried Blood Spot (DBS) Testing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dried Blood Spot (DBS) Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Dried Blood Spot (DBS) Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dried Blood Spot (DBS) Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dried Blood Spot (DBS) Testing Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

The global Dried Blood Spot (DBS) Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Dried Blood Spot (DBS) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dried Blood Spot (DBS) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dried Blood Spot (DBS) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dried Blood Spot (DBS) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Dried Blood Spot (DBS) Testing include ZRT Laboratory, Randox Laboratories, RDA Spot, Lipomic, CRL, HemaXis, EUROIMMUN, Boston Heart Diagnostics and Kurukankarti, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Dried Blood Spot (DBS) Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dried Blood Spot (DBS) Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Dried Blood Spot (DBS) Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dried Blood Spot (DBS) Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dried Blood Spot (DBS) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Dried Blood Spot (DBS) Testing revenue, projected growth trends, production technology, application and end-user industry.

Dried Blood Spot (DBS) Testing Segment by Company

ZRT Laboratory

Randox Laboratories

RDA Spot

Lipomic

CRL

HemaXis

EUROIMMUN

Boston Heart Diagnostics

Kurukankarti

Capitainer

Dried Blood Spot (DBS) Testing Segment by Type

Testing Card

Testing Kit

Dried Blood Spot (DBS) Testing Segment by Application

HIV Test

Hepatitis C Test

Others

Dried Blood Spot (DBS) Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dried Blood Spot (DBS) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dried Blood Spot (DBS) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dried Blood Spot (DBS) Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Dried Blood Spot (DBS) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Dried Blood Spot (DBS) Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dried Blood Spot (DBS) Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dried Blood Spot (DBS) Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Testing Card Major Player Table 3. Testing Kit Major Player Table 4. Global Dried Blood Spot (DBS) Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. HIV Test Major Player Table 6. Hepatitis C Test Major Player Table 7. Others Major Player Table 8. Dried Blood Spot (DBS) Testing Industry Trends Table 9. Dried Blood Spot (DBS) Testing Industry Drivers Table 10. Dried Blood Spot (DBS) Testing Industry Opportunities and Challenges Table 11. Dried Blood Spot (DBS) Testing Industry Restraints Table 12. Global Dried Blood Spot (DBS) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Dried Blood Spot (DBS) Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Dried Blood Spot (DBS) Testing Market Share by Region (2021-2026) Table 15. Global Dried Blood Spot (DBS) Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Dried Blood Spot (DBS) Testing Market Share by Region (2027-2032) Table 17. Global Dried Blood Spot (DBS) Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Players (2021-2026) Table 19. Global Dried Blood Spot (DBS) Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Dried Blood Spot (DBS) Testing Key Players Headquarters & Area Served Table 21. Global Dried Blood Spot (DBS) Testing Players, Product Type & Application Table 22. Global Dried Blood Spot (DBS) Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Dried Blood Spot (DBS) Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Dried Blood Spot (DBS) Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Type (2021-2026) Table 29. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Type (2027-2032) Table 30. Global Dried Blood Spot (DBS) Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Application (2021-2026) Table 34. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Application (2027-2032) Table 35. ZRT Laboratory Company Information Table 36. ZRT Laboratory Business Overview Table 37. ZRT Laboratory Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. ZRT Laboratory Dried Blood Spot (DBS) Testing Product Portfolio Table 39. ZRT Laboratory Recent Development Table 40. Randox Laboratories Company Information Table 41. Randox Laboratories Business Overview Table 42. Randox Laboratories Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Randox Laboratories Dried Blood Spot (DBS) Testing Product Portfolio Table 44. Randox Laboratories Recent Development Table 45. RDA Spot Company Information Table 46. RDA Spot Business Overview Table 47. RDA Spot Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. RDA Spot Dried Blood Spot (DBS) Testing Product Portfolio Table 49. RDA Spot Recent Development Table 50. Lipomic Company Information Table 51. Lipomic Business Overview Table 52. Lipomic Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Lipomic Dried Blood Spot (DBS) Testing Product Portfolio Table 54. Lipomic Recent Development Table 55. CRL Company Information Table 56. CRL Business Overview Table 57. CRL Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. CRL Dried Blood Spot (DBS) Testing Product Portfolio Table 59. CRL Recent Development Table 60. HemaXis Company Information Table 61. HemaXis Business Overview Table 62. HemaXis Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. HemaXis Dried Blood Spot (DBS) Testing Product Portfolio Table 64. HemaXis Recent Development Table 65. EUROIMMUN Company Information Table 66. EUROIMMUN Business Overview Table 67. EUROIMMUN Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. EUROIMMUN Dried Blood Spot (DBS) Testing Product Portfolio Table 69. EUROIMMUN Recent Development Table 70. Boston Heart Diagnostics Company Information Table 71. Boston Heart Diagnostics Business Overview Table 72. Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Product Portfolio Table 74. Boston Heart Diagnostics Recent Development Table 75. Kurukankarti Company Information Table 76. Kurukankarti Business Overview Table 77. Kurukankarti Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Kurukankarti Dried Blood Spot (DBS) Testing Product Portfolio Table 79. Kurukankarti Recent Development Table 80. Capitainer Company Information Table 81. Capitainer Business Overview Table 82. Capitainer Dried Blood Spot (DBS) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Capitainer Dried Blood Spot (DBS) Testing Product Portfolio Table 84. Capitainer Recent Development Table 85. North America Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Dried Blood Spot (DBS) Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Dried Blood Spot (DBS) Testing Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Dried Blood Spot (DBS) Testing Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Dried Blood Spot (DBS) Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Dried Blood Spot (DBS) Testing Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Dried Blood Spot (DBS) Testing Revenue by Country (US$ Million) & (2027-2032) Table 99. China Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026) & (US$ Million) Table 100. China Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032) & (US$ Million) Table 101. China Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026) & (US$ Million) Table 102. China Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Dried Blood Spot (DBS) Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Dried Blood Spot (DBS) Testing Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Dried Blood Spot (DBS) Testing Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Dried Blood Spot (DBS) Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Dried Blood Spot (DBS) Testing Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Dried Blood Spot (DBS) Testing Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Dried Blood Spot (DBS) Testing Image Figure 2. Global Dried Blood Spot (DBS) Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dried Blood Spot (DBS) Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Testing Card Image Figure 5. Testing Kit Image Figure 6. Global Dried Blood Spot (DBS) Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dried Blood Spot (DBS) Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. HIV Test Image Figure 9. Hepatitis C Test Image Figure 10. Others Image Figure 11. Global Dried Blood Spot (DBS) Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global Dried Blood Spot (DBS) Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Dried Blood Spot (DBS) Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Dried Blood Spot (DBS) Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Dried Blood Spot (DBS) Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Dried Blood Spot (DBS) Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Type (2021-2032) Figure 19. Global Dried Blood Spot (DBS) Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Dried Blood Spot (DBS) Testing Revenue Market Share by Application (2021-2032) Figure 22. North America Dried Blood Spot (DBS) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032) Figure 24. North America Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032) Figure 25. North America Dried Blood Spot (DBS) Testing Revenue Share by Country (2021-2032) Figure 26. United States Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Dried Blood Spot (DBS) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032) Figure 31. Europe Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032) Figure 32. Europe Dried Blood Spot (DBS) Testing Revenue Share by Country (2021-2032) Figure 33. Germany Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Dried Blood Spot (DBS) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032) Figure 43. China Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032) Figure 44. Asia Dried Blood Spot (DBS) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032) Figure 46. Asia Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032) Figure 47. Asia Dried Blood Spot (DBS) Testing Revenue Share by Region (2021-2032) Figure 48. Japan Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Dried Blood Spot (DBS) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA Dried Blood Spot (DBS) Testing Revenue Share by Country (2021-2032) Figure 58. Brazil Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Dried Blood Spot (DBS) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Testing Card
  • Testing Kit
Applications
  • HIV Test
  • Hepatitis C Test
  • Others
Companies covered
  • ZRT Laboratory
  • Randox Laboratories
  • RDA Spot
  • Lipomic
  • CRL
  • HemaXis
  • EUROIMMUN
  • Boston Heart Diagnostics
  • Kurukankarti
  • Capitainer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dried Blood Spot (DBS) Testing Market by Type
  3. 1.2.1 Global Dried Blood Spot (DBS) Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Testing Card
  5. 1.2.3 Testing Kit
  6. 1.3 Dried Blood Spot (DBS) Testing Market by Application
  7. 1.3.1 Global Dried Blood Spot (DBS) Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 HIV Test
  9. 1.3.3 Hepatitis C Test
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dried Blood Spot (DBS) Testing Market Dynamics
  1. 2.1 Dried Blood Spot (DBS) Testing Industry Trends
  2. 2.2 Dried Blood Spot (DBS) Testing Industry Drivers
  3. 2.3 Dried Blood Spot (DBS) Testing Industry Opportunities and Challenges
  4. 2.4 Dried Blood Spot (DBS) Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Dried Blood Spot (DBS) Testing Market Perspective (2021-2032)
  2. 3.2 Global Dried Blood Spot (DBS) Testing Growth Trends by Region
  3. 3.2.1 Global Dried Blood Spot (DBS) Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dried Blood Spot (DBS) Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Dried Blood Spot (DBS) Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Dried Blood Spot (DBS) Testing Revenue by Players
  2. 4.1.1 Global Dried Blood Spot (DBS) Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Dried Blood Spot (DBS) Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Dried Blood Spot (DBS) Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dried Blood Spot (DBS) Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Dried Blood Spot (DBS) Testing Key Players Headquarters & Area Served
  7. 4.4 Global Dried Blood Spot (DBS) Testing Players, Product Type & Application
  8. 4.5 Global Dried Blood Spot (DBS) Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Dried Blood Spot (DBS) Testing Market CR5 and HHI
  11. 4.6.3 2025 Dried Blood Spot (DBS) Testing Tier 1, Tier 2, and Tier 3
5 Dried Blood Spot (DBS) Testing Market Size by Type
  1. 5.1 Global Dried Blood Spot (DBS) Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Dried Blood Spot (DBS) Testing Revenue by Type (2021-2032)
  3. 5.3 Global Dried Blood Spot (DBS) Testing Revenue Market Share by Type (2021-2032)
6 Dried Blood Spot (DBS) Testing Market Size by Application
  1. 6.1 Global Dried Blood Spot (DBS) Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Dried Blood Spot (DBS) Testing Revenue by Application (2021-2032)
  3. 6.3 Global Dried Blood Spot (DBS) Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ZRT Laboratory
  2. 7.1.1 ZRT Laboratory Company Information
  3. 7.1.2 ZRT Laboratory Business Overview
  4. 7.1.3 ZRT Laboratory Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ZRT Laboratory Dried Blood Spot (DBS) Testing Product Portfolio
  6. 7.1.5 ZRT Laboratory Recent Developments
  7. 7.2 Randox Laboratories
  8. 7.2.1 Randox Laboratories Company Information
  9. 7.2.2 Randox Laboratories Business Overview
  10. 7.2.3 Randox Laboratories Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Randox Laboratories Dried Blood Spot (DBS) Testing Product Portfolio
  12. 7.2.5 Randox Laboratories Recent Developments
  13. 7.3 RDA Spot
  14. 7.3.1 RDA Spot Company Information
  15. 7.3.2 RDA Spot Business Overview
  16. 7.3.3 RDA Spot Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 RDA Spot Dried Blood Spot (DBS) Testing Product Portfolio
  18. 7.3.5 RDA Spot Recent Developments
  19. 7.4 Lipomic
  20. 7.4.1 Lipomic Company Information
  21. 7.4.2 Lipomic Business Overview
  22. 7.4.3 Lipomic Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lipomic Dried Blood Spot (DBS) Testing Product Portfolio
  24. 7.4.5 Lipomic Recent Developments
  25. 7.5 CRL
  26. 7.5.1 CRL Company Information
  27. 7.5.2 CRL Business Overview
  28. 7.5.3 CRL Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CRL Dried Blood Spot (DBS) Testing Product Portfolio
  30. 7.5.5 CRL Recent Developments
  31. 7.6 HemaXis
  32. 7.6.1 HemaXis Company Information
  33. 7.6.2 HemaXis Business Overview
  34. 7.6.3 HemaXis Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 HemaXis Dried Blood Spot (DBS) Testing Product Portfolio
  36. 7.6.5 HemaXis Recent Developments
  37. 7.7 EUROIMMUN
  38. 7.7.1 EUROIMMUN Company Information
  39. 7.7.2 EUROIMMUN Business Overview
  40. 7.7.3 EUROIMMUN Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 EUROIMMUN Dried Blood Spot (DBS) Testing Product Portfolio
  42. 7.7.5 EUROIMMUN Recent Developments
  43. 7.8 Boston Heart Diagnostics
  44. 7.8.1 Boston Heart Diagnostics Company Information
  45. 7.8.2 Boston Heart Diagnostics Business Overview
  46. 7.8.3 Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Product Portfolio
  48. 7.8.5 Boston Heart Diagnostics Recent Developments
  49. 7.9 Kurukankarti
  50. 7.9.1 Kurukankarti Company Information
  51. 7.9.2 Kurukankarti Business Overview
  52. 7.9.3 Kurukankarti Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Kurukankarti Dried Blood Spot (DBS) Testing Product Portfolio
  54. 7.9.5 Kurukankarti Recent Developments
  55. 7.10 Capitainer
  56. 7.10.1 Capitainer Company Information
  57. 7.10.2 Capitainer Business Overview
  58. 7.10.3 Capitainer Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Capitainer Dried Blood Spot (DBS) Testing Product Portfolio
  60. 7.10.5 Capitainer Recent Developments
8 North America
  1. 8.1 North America Dried Blood Spot (DBS) Testing Revenue (2021-2032)
  2. 8.2 North America Dried Blood Spot (DBS) Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032)
  5. 8.3 North America Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Dried Blood Spot (DBS) Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032)
  9. 8.5 North America Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Dried Blood Spot (DBS) Testing Revenue by Country
  11. 8.6.1 North America Dried Blood Spot (DBS) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Dried Blood Spot (DBS) Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Dried Blood Spot (DBS) Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Dried Blood Spot (DBS) Testing Revenue (2021-2032)
  2. 9.2 Europe Dried Blood Spot (DBS) Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Dried Blood Spot (DBS) Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Dried Blood Spot (DBS) Testing Revenue by Country
  11. 9.6.1 Europe Dried Blood Spot (DBS) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Dried Blood Spot (DBS) Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Dried Blood Spot (DBS) Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Dried Blood Spot (DBS) Testing Revenue (2021-2032)
  2. 10.2 China Dried Blood Spot (DBS) Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032)
  5. 10.3 China Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Dried Blood Spot (DBS) Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032)
  9. 10.5 China Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dried Blood Spot (DBS) Testing Revenue (2021-2032)
  2. 11.2 Asia Dried Blood Spot (DBS) Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Dried Blood Spot (DBS) Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Dried Blood Spot (DBS) Testing Revenue by Country
  11. 11.6.1 Asia Dried Blood Spot (DBS) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Dried Blood Spot (DBS) Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Dried Blood Spot (DBS) Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dried Blood Spot (DBS) Testing Revenue (2021-2032)
  2. 12.2 SAMEA Dried Blood Spot (DBS) Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Dried Blood Spot (DBS) Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Dried Blood Spot (DBS) Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Dried Blood Spot (DBS) Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Dried Blood Spot (DBS) Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Dried Blood Spot (DBS) Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Dried Blood Spot (DBS) Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Dried Blood Spot (DBS) Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Dried Blood Spot (DBS) Testing Revenue by Country
  11. 12.6.1 SAMEA Dried Blood Spot (DBS) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Dried Blood Spot (DBS) Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Dried Blood Spot (DBS) Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst